Melanie Guyot

Valbonne, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

The cholinergic anti-inflammatory pathway inhibits inflammation without lymphocyte relay.

The cholinergic anti-inflammatory pathway inhibits inflammation without lymphocyte relay.

Journal: Frontiers in neuroscience

Published: December 16, 2022

Environmental signals perceived by the brain abate pro-metastatic monocytes by dampening glucocorticoids receptor signaling.

Environmental signals perceived by the brain abate pro-metastatic monocytes by dampening glucocorticoids receptor signaling.

Journal: Cancer cell international

Published: November 12, 2022

The combination of bevacizumab/Avastin and erlotinib/Tarceva is relevant for the treatment of metastatic renal cell carcinoma: the role of a synonymous mutation of the EGFR receptor.

The combination of bevacizumab/Avastin and erlotinib/Tarceva is relevant for the treatment of metastatic renal cell carcinoma: the role of a synonymous mutation of the EGFR receptor.

Journal: Theranostics

Published: July 11, 2019

Apical splenic nerve electrical stimulation discloses an anti-inflammatory pathway relying on adrenergic and nicotinic receptors in myeloid cells.

Apical splenic nerve electrical stimulation discloses an anti-inflammatory pathway relying on adrenergic and nicotinic receptors in myeloid cells.

Journal: Brain, behavior, and immunity

Published: December 21, 2018

CD8+ T cells are essential for the effects of enriched environment on hippocampus-dependent behavior, hippocampal neurogenesis and synaptic plasticity.

CD8+ T cells are essential for the effects of enriched environment on hippocampus-dependent behavior, hippocampal neurogenesis and synaptic plasticity.

Journal: Brain, behavior, and immunity

Published: July 18, 2017

Pancreatic nerve electrostimulation inhibits recent-onset autoimmune diabetes.

Pancreatic nerve electrostimulation inhibits recent-onset autoimmune diabetes.

Journal: Nature biotechnology

Published: June 19, 2017

CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas.

CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas.

Journal: British journal of cancer

Published: April 27, 2017

Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies.

Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies.

Journal: Oncotarget

Published: October 13, 2016

VEGF Splicing and the Role of VEGF Splice Variants: From Physiological-Pathological Conditions to Specific Pre-mRNA Splicing.

VEGF Splicing and the Role of VEGF Splice Variants: From Physiological-Pathological Conditions to Specific Pre-mRNA Splicing.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: August 20, 2015

The ELR+CXCL chemokines and their receptors CXCR1/CXCR2: A signaling axis and new target for the treatment of renal cell carcinoma.

The ELR+CXCL chemokines and their receptors CXCR1/CXCR2: A signaling axis and new target for the treatment of renal cell carcinoma.

Journal: Oncoimmunology

Published: February 20, 2014

The CXCL7/CXCR1/2 axis is a key driver in the growth of clear cell renal cell carcinoma.

The CXCL7/CXCR1/2 axis is a key driver in the growth of clear cell renal cell carcinoma.

Journal: Cancer research

Published: December 17, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026